Woodline Partners LP Geron Corp Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Geron Corp stock. As of the latest transaction made, Woodline Partners LP holds 16,951,016 shares of GERN stock, worth $75.1 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
16,951,016
Previous 1,214,570
1295.64%
Holding current value
$75.1 Million
Previous $4.01 Million
1693.21%
% of portfolio
0.72%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
258Shares Held
448MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$206 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$205 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$141 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$121 Million17.06% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$106 Million12.26% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.67B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...